CD19 and infection: Therefore, as CD19 or BCMA-directed CAR-T therapy administration increases, management of hypogammaglobulinemia with an infusion of IVIG monthly to maintain a goal IgG ≥ 400mg/dL, particularly if recurrent/severe infections occur, can be considered to mitigate the risk of infections [94].